Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janaki Amin

Showing results (101-110 of 196) with videos related to

Pageof 20
Sort By:
BMJ Open|October 10, 2012
The importance of blood-borne viruses in elevated cancer risk among opioid-dependent people: a population-based cohort studyAlexander Swart, Lucinda Burns, Limin Mao, et al.
AIDS (London, England)|May 23, 2012
Reclassification of risk of death with the knowledge of D-dimer in a cohort of treated HIV-infected individualsAmit C Achhra, Janaki Amin, Caroline Sabin, et al.
JMIR Research Protocols|April 24, 2020
Monitoring Health and Well-Being in Emerging Adults: Protocol for a Pilot Longitudinal Cohort StudyReidar P Lystad, Diana Fajardo Pulido, Lorna Peters, et al.
JMIR Formative Research|January 6, 2022
Feasibility of Monitoring Health and Well-being in Emerging Adults: Pilot Longitudinal Cohort StudyReidar P Lystad, Diana Fajardo Pulido, Lorna Peters, et al.
CMAJ Open|August 1, 2014
Mortality in a large community-based cohort of inner-city residents in Vancouver, CanadaGregory D Deans, Jesse D Raffa, Calvin Lai, et al.
Immunology|November 24, 2012
Specific antibody-dependent cellular cytotoxicity responses associated with slow progression of HIV infectionLeia H Wren, Amy W Chung, Gamze Isitman, et al.
Journal of Gastroenterology and Hepatology|May 21, 2016
Chronic hepatitis C burden and care cascade in Australia in the era of interferon-based treatmentBehzad Hajarizadeh, Jason Grebely, Hamish McManus, et al.
The Lancet Regional Health. Western Pacific|September 16, 2024
Trends in viral hepatitis liver-related morbidity and mortality in New South Wales, AustraliaShane Tillakeratne, Sallie-Anne Pearson, Maryam Alavi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 30, 2014
Bone mineral density over 96 weeks in adults failing first-line therapy randomized to raltegravir/lopinavir/ritonavir compared with standard second-line therapyHila Haskelberg, Patrick W G Mallon, Jennifer Hoy, et al.
AIDS (London, England)|March 3, 2015
Early antiretroviral therapy with raltegravir generates sustained reductions in HIV reservoirs but not lower T-cell activation levelsWilliam J Hey-Cunningham, John M Murray, Ven Natarajan, et al.
Pageof 20

Showing results (101-110 of 196) with videos related to

Sort By:
Pageof 20
BMJ Open|October 10, 2012
The importance of blood-borne viruses in elevated cancer risk among opioid-dependent people: a population-based cohort studyAlexander Swart, Lucinda Burns, Limin Mao, et al.
AIDS (London, England)|May 23, 2012
Reclassification of risk of death with the knowledge of D-dimer in a cohort of treated HIV-infected individualsAmit C Achhra, Janaki Amin, Caroline Sabin, et al.
JMIR Research Protocols|April 24, 2020
Monitoring Health and Well-Being in Emerging Adults: Protocol for a Pilot Longitudinal Cohort StudyReidar P Lystad, Diana Fajardo Pulido, Lorna Peters, et al.
JMIR Formative Research|January 6, 2022
Feasibility of Monitoring Health and Well-being in Emerging Adults: Pilot Longitudinal Cohort StudyReidar P Lystad, Diana Fajardo Pulido, Lorna Peters, et al.
CMAJ Open|August 1, 2014
Mortality in a large community-based cohort of inner-city residents in Vancouver, CanadaGregory D Deans, Jesse D Raffa, Calvin Lai, et al.
Immunology|November 24, 2012
Specific antibody-dependent cellular cytotoxicity responses associated with slow progression of HIV infectionLeia H Wren, Amy W Chung, Gamze Isitman, et al.
Journal of Gastroenterology and Hepatology|May 21, 2016
Chronic hepatitis C burden and care cascade in Australia in the era of interferon-based treatmentBehzad Hajarizadeh, Jason Grebely, Hamish McManus, et al.
The Lancet Regional Health. Western Pacific|September 16, 2024
Trends in viral hepatitis liver-related morbidity and mortality in New South Wales, AustraliaShane Tillakeratne, Sallie-Anne Pearson, Maryam Alavi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 30, 2014
Bone mineral density over 96 weeks in adults failing first-line therapy randomized to raltegravir/lopinavir/ritonavir compared with standard second-line therapyHila Haskelberg, Patrick W G Mallon, Jennifer Hoy, et al.
AIDS (London, England)|March 3, 2015
Early antiretroviral therapy with raltegravir generates sustained reductions in HIV reservoirs but not lower T-cell activation levelsWilliam J Hey-Cunningham, John M Murray, Ven Natarajan, et al.
Pageof 20